药品注册申请号:205152
申请类型:ANDA (仿制药申请)
申请人:MYLAN
申请人全名:MYLAN PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE No No AB 2017/08/11 2017/08/11 Prescription
002 ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE No No AB 2017/08/11 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/09/30 SUPPL-1(补充) Approval Labeling STANDARD
2017/08/11 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ELETRIPTAN HYDROBROMIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 20MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021016 001 NDA RELPAX ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription Yes No AB 2002/12/26 UPJOHN
206409 001 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription No No AB 2017/06/16 ZYDUS PHARMS
202040 001 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription No No AB 2017/06/27 TEVA PHARMS USA
205152 001 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription No No AB 2017/08/11 MYLAN
205186 001 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription No No AB 2017/08/29 AJANTA PHARMA LTD
210708 001 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription No No AB 2019/01/15 AUROBINDO PHARMA
215467 001 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Prescription No No AB 2022/07/13 BEXIMCO PHARMS USA
活性成分:ELETRIPTAN HYDROBROMIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 40MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021016 002 NDA RELPAX ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription Yes Yes AB 2002/12/26 UPJOHN
206409 002 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription No No AB 2017/06/16 ZYDUS PHARMS
202040 002 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription No No AB 2017/06/27 TEVA PHARMS USA
205152 002 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription No No AB 2017/08/11 MYLAN
205186 002 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription No No AB 2017/08/29 AJANTA PHARMA LTD
210708 002 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription No No AB 2019/01/15 AUROBINDO PHARMA
215467 002 ANDA ELETRIPTAN HYDROBROMIDE ELETRIPTAN HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Prescription No No AB 2022/07/13 BEXIMCO PHARMS USA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database